Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
PCDG9Q9Y5G4Protocadherin gamma-A9 (PCDH-gamma-A9)Predicted membrane proteins1Adhesion and uptake mediation30.50
PGAP3Q96FM1GPI-specific phospholipase A2-like PGAP3 (EC 3.1.1.-) (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1) (Post-GPI attachment to proteins factor 3)Disease related genesHuman disease related genesPredicted intracellular proteins7Metabolism mediation30.50
PGFRAP16234Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a)Cancer-related genesCD markersDisease related genes1Acute myeloid leukaemiaBCR-ABL1-negative chronic myeloid leukaemiaBrain cancerClinical-translation mediationFusion and delivery mediationImmune mediation30.50
PPB1P05187Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)Cancer-related genesEnzymesMetabolic proteins1Fusion and delivery mediation30.50
PTPRMP28827Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)EnzymesPlasma proteinsPredicted intracellular proteins1Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation30.50
ROBO2Q9HCK4Roundabout homolog 2Disease related genesHuman disease related genesPlasma proteins1Adhesion and uptake mediation30.50
ROBO3Q96MS0Roundabout homolog 3 (Roundabout-like protein 3)1Adhesion and uptake mediation30.50
S22AGQ86VW1Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6)Metabolic proteinsPredicted membrane proteinsTransporters12Fusion and delivery mediation30.50
SCN3BQ9NY72Sodium channel regulatory subunit beta-31Fusion and delivery mediation30.50
SMAGPQ0VAQ4Small cell adhesion glycoprotein (Small transmembrane and glycosylated protein)Predicted intracellular proteinsPredicted membrane proteins1Other mediation30.50
TM252Q8N6L7Transmembrane protein 252Predicted membrane proteins2Other mediation30.50
TM254Q8TBM7Transmembrane protein 254Predicted membrane proteins3Other mediation30.50
TM268Q5VZI3Transmembrane protein 268Predicted membrane proteins2Other mediation30.50
TM50AO95807Transmembrane protein 50A (Small membrane protein 1)4Other mediation30.50
TNR16P08138Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (Low-affinity nerve growth factor receptor p75NGFR) (Low-affinity nerve growth factor receptor p75NGR) (p75 ICD) (CD antigen CD271)Cancer-related genesCD markersPredicted intracellular proteins1Alzheimer diseaseCerebral ischaemiaChronic painClinical-translation mediationMetabolism mediationReceptor-signaling mediation30.50
ZDHC5Q9C0B5Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375)EnzymesMetabolic proteinsPlasma proteins4Clinical-translation mediationFusion and delivery mediationImmune mediation30.50
4F2P08195Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)Cancer-related genesCD markersEssential proteins1Acute myeloid leukaemiaClinical-translation mediationFusion and delivery mediationImmune mediation20.50
5HT1BP282225-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Alzheimer diseaseAnxiety disorderAttention deficit hyperactivity disorderClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
5HT7RP349695-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Alzheimer diseaseAttention deficit hyperactivity disorderBipolar disorderClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
AA2BRP29275Adenosine receptor A2b7Alzheimer diseaseAsthmaBreathing abnormalityClinical-translation mediationFusion and delivery mediationImmune mediation20.50
ACHA3P32297Neuronal acetylcholine receptor subunit alpha-3Disease related genesFDA approved drug targetsPredicted intracellular proteins4Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
ACM3P20309Muscarinic acetylcholine receptor M3Disease related genesFDA approved drug targetsG-protein coupled receptors7Abnormal micturitionAlzheimer diseaseAsthmaClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
ANO2Q9NQ90Anoctamin-2 (Transmembrane protein 16B)Predicted membrane proteinsTransporters8Clinical-translation mediationFusion and delivery mediation20.50
ANO6Q4KMQ2Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F)Disease related genesHuman disease related genesPotential drug targets10Clinical-translation mediationFusion and delivery mediationImmune mediation20.50
APLD1Q96LR9Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein)Predicted membrane proteins3Fusion and delivery mediation20.50

201-225 of 1,200 proteins

Page